Zhang L, et al. (2022) An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2. bioRxiv
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.